Nitric oxide synthase expression and enzymatic activity in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 109, Issue 4, 2004, Pages 261-269

  Broholm, H ^a   Andersen, B ^a   Wanscher, B ^a,b   Frederiksen, J L ^a   Rubin, I ^a,b   Pakkenberg, B ^c   Larsson, H B W ^d   Lauritzen, M ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Cytotoxicity; Magnetic resonance imaging; Multiple sclerosis; Nitric oxide synthase; NOS enzymatic activity; NOS immunohistochemistry; Oligodendrocytes

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN BIOPSY; BRAIN REGION; CADAVER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GRAY MATTER; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; SENILE PLAQUE; VASCULAR ENDOTHELIUM;

ADULT; AGED; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; ISOENZYMES; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROGLIA; NITRIC OXIDE SYNTHASE;

EID: 1642524991     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2004.00207.x     Document Type: Article

References (36)

1. BÖ L, DAWSON TM, WESSELINGH S et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36:778-86.
2. BÖ L, MORK S, KONG PA, NYLAND H, PARDO CA, TRAPP BD. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994;51: 135-46.
3. XIAO BG, LINK H. Immune regulation within the central nervous system. J Neurol Sci 1998;157:1-12.
4. HARTUNG HP, JUNG S, STOLL G et al. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 1992;40:197-210.
5. LIU JS, ZHAO ML, BROSNAN CF, LEE SC. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001;158:2057-66.
6. PARK KG, HAYES PD, GARLICK PJ, SEWELL H, EREMIN O. Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 1991;337:645-6.
7. KOLB H, KOLB-BACHOFEN V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 1992;13:157-60.
8. PARKINSON JF, MITROVIC B, MERRILL JE. The role of nitric oxide in multiple sclerosis. J Mol Med 1997;75:174-86.
9. OKUDA Y, NAKATSUJI Y, FUJIMURA H et al. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J Neuroimmunol 1995;62:103-12.
10. KOPROWSKI H, ZHENG YM, HEBER-KATZ E et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 1993;90:3024-7.
11. CROSS AH, KEELING RM, GOORHA S et al. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J Neuroimmunol 1996;71:145-53.
12. CROSS AH, MISKO TP, LIN RF, HICKEY WF, TROTTER JL, TILTON RG. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest 1994;93:2684-90.
13. BAGASRA O, MICHAELS FH, ZHENG YM et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995;92:12041-5.
14. OLESZAK EL, ZACZYNSKA E, BHATTACHARJEE M, BUTUNOI C, LEGIDO A, KATSETOS CD. Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin Diagn Lab Immunol 1998;5:438-45.
15. DE GROOT CJ, RUULS SR, THEEUWES JW, DIJKSTRA CD, VAN DER VALK P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997;56:10-20.
16. REDFORD EJ, KAPOOR R, SMITH KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997;120(Pt 12):2149-57.
17. DE GROOT CJ, BERGERS E, KAMPHORST W et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001;124:1635-45.
18. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
19. LUBLIN FD, REINGOLD SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907-11.
20. VAN DER VALK P, DE GROOT CJA. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000;26:2-10.
21. EGBERONGBE YI, GENTLEMAN SM, FALKAI P, BOGERTS B, POLAK JM, ROBERTS GW. The distribution of nitric oxide synthase immunoreactivity in the human brain. Neuroscience 1994;59:561-78.
22. SPARROW JR. Inducible nitric oxide synthase in the central nervous system. J Mol Neurosci 1994;5:219-29.
23. FAZEKAS F, BARKHOF F, FILIPPI M et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999;53:448-56.
24. MCDONALD WI, MILLER DH, BARNES D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992;18:319-34.
25. PATY DW, OGER JJ, KASTRUKO LF et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180-5.
26. WAYNE MOORE GR. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? J Neurol Sci 2003;206:175-9.
27. NIJEHOLT GJ, BERGERS E, KAMPHORST W et al. Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain 2001;124:154-66.
28. TRAN EH, HARDIN-POUZET H, VERGE G, OWENS T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J Neuroimmunol 1997;74:121-9.
29. MERRILL JE, IGNARRO LJ, SHERMAN MP, MELLNEK J, LANE TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993;151:2132-41.
30. MURPHY S, SIMMONS ML, AGULLO L et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 1993;16:323-8.
31. GALEA E, FEINSTEIN DL, REIS DJ. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci USA 1992;89:10945-9.
32. LEE SC, DICKSON DW, LIU W, BROSNAN CF. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 1993;46:19-24.
33. ZIELASEK J, JUNG S, GOLD R, LIEW FY, TOYKA KV, HARTUNG HP. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J Neuroimmunol 1995;58:81-8.
34. BROSNAN CF, BATTISTINI L, RAINE CS, DICKSON DW, CASADEVALL A, LEE SC. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994;16:152-61.
35. CHAO CC, HU S, MOLITOR TW, SHASKAN EG, PETERSON PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992;149:2736-41.
36. CHAO CC, MOLITOR TW, HU S. Neuroprotective role of IL-4 against activated microglia. J Immunol 1993;151:1473-81.